THOMEER, Michiel

Email Alert RSS Feed

Profile

Full Name
THOMEER, Michiel
Email
michiel.thomeer@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Type:  Journal Contribution

Results 41-60 of 65 (Search time: 0.015 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
412016Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)Kreuter, Michael; Vansteenkiste, Johan; Fischer, Jürgen; Eberhardt, Wilfried; Zabeck, Heike; Kollmeier, Jens; Serke, Monika; Frickhofen, Norbert; Reck, Martin; Engel-Riedel, Walburga; Neumann, Silke; THOMEER, Michiel; Schumann, Christian; De Leyn, Paul; Graeter, Thomas; Stamatis, Georgios; Griesinger, Frank; Thomas, MichaelJournal ContributionA1
422016Detection of Lung Cancer through Metabolic Changes Measured in Blood PlasmaLOUIS, Evelyne; ADRIAENSENS, Peter; GUEDENS, Wanda; BIGIRUMURAME, Theophile; BAETEN, Kurt; VANHOVE, Karolien; Vandeurzen, Kurt; Darquennes, Karen; Vansteenkiste, Johan; Dooms, Christophe; SHKEDY, Ziv; MESOTTEN, Liesbet; THOMEER, MichielJournal ContributionA1
432016Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?LOUIS, Evelyne; ADRIAENSENS, Peter; GUEDENS, Wanda; VANHOVE, Karolien; Vandeurzen, Kurt; Darquennes, Karen; Vansteenkiste, Johan; Dooms, Christophe; DE JONGE, Eric; THOMEER, Michiel; MESOTTEN, LiesbetJournal ContributionA1
442015Prognostic value of quantitative FDG PET/CT uptake metrics in NSCLCVANHOVE, Karolien; Liesbet, Mesotten; LOUIS, Evelyne; THOMEER, Michiel; ADRIAENSENS, Peter; Boellaard, RonaldJournal ContributionM
452015Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung CancerPujol, Jean-Louis; Vansteenkiste, Johan F.; De Pas, Tommaso Martino; Atanackovic, Djordje; Reck, Martin; THOMEER, Michiel; Douillard, Jean-Yves; Fasola, Gianpiero; Potter, Vanessa; Taylor, Paul; Bosquee, Lionel; Scheubel, Robert; Jarnjak, Silvija; Debois, Muriel; Alves, Pedro de Sousa; Louahed, Jamila; Brichard, Vincent G.; Lehmann, Frederic F.Journal ContributionA1
462015Metabolomics a novel biomarker in lung cancerSTINKENS, Kirsten; VANHOVE, Karolien; THOMEER, MichielJournal ContributionA1
4720152015, big data in healthcare: for whom the bell tolls?VAN POUCKE, Sven; THOMEER, Michiel; HADZIC, AJournal ContributionA1
482015Phenotyping human blood plasma by 1H-NMR: a robust protocol based on metabolite spiking and its evaluation in breast cancerLOUIS, Evelyne; BERVOETS, Liene; REEKMANS, Gunter; DE JONGE, Eric; MESOTTEN, Liesbet; THOMEER, Michiel; ADRIAENSENS, PeterJournal ContributionA1
492015Influence of preanalytical sampling conditions on the 1 H NMR metabolic profile of human blood plasma and introduction of the Standard PREanalytical Code used in biobankingBERVOETS, Liene; LOUIS, Evelyne; REEKMANS, Gunter; MESOTTEN, Liesbet; THOMEER, Michiel; ADRIAENSENS, Peter; LINSEN, LoesJournal ContributionA1
502014Prognostic value of total lesion glycolysis and metabolic tumor volume in non-small cell lung cancerVANHOVE, Karolien; Heylen, Micheline; Derwael, Ruben; LOUIS, Evelyne; THOMEER, Michiel; MESOTTEN, Liesbet; ADRIAENSENS, Peter; Boellaard, RonaldJournal ContributionM
512014Linguistic correction evaluation of 1H-NMR spectroscopy in predicting platine-related toxicities in lung cancer patientsVANHOVE, Karolien; THOMEER, Michiel; MESOTTEN, Liesbet; LOUIS, Evelyne; ADRIAENSENS, PeterJournal ContributionM
522014Validation of 1H-NMR-based metabolomics as a tool to detect lung cancer in human blood plasmaTHOMEER, Michiel; LOUIS, Evelyne; MESOTTEN, Liesbet; VANHOVE, Karolien; Vandeurzen, K.; Sadowska, A.; REEKMANS, Gunter; ADRIAENSENS, PeterJournal ContributionM
532014Validation of 1H-NMR-based metabolomics as a tool to detect lung cancer in human blood plasmaLOUIS, Evelyne; THOMEER, Michiel; MESOTTEN, Liesbet; VANHOVE, Karolien; Vandeurzen, Kurt; Sadowska, Anna; REEKMANS, Gunter; ADRIAENSENS, PeterJournal ContributionM
542013Profylaxe tegen Pneumocystis jiroveci-pneumonie: Nuttig bij patiënten zonder hiv-infectie of transplantatie?Huskens, M.; THOMEER, Michiel; MEEUWISSEN, JorisJournal ContributionA1
552013Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT studyKreuter, M; Vansteenkiste, J; Fischer, J; Eberhardt, W; Zabeck, H; Kollmeier, J; Serke, M; Frickhofen, N; Reck, M; Engel-Riedel, W; Neumann, S; THOMEER, Michiel; Schumann, C; De Leyn, P; Graeter, T; Stamatis, G; Zuna, I; Griesinger, F; Thomas, MJournal ContributionA1
562013Methotrexate vs Azathioprine in Second-line Therapy of SarcoidosisVorselaars, Adriane D. M.; Wuyts, Wim A.; Vorselaars, Veronique M. M.; Zanen, Pieter; Deneer, Vera H. M.; Veltkamp, Marcel; THOMEER, Michiel; van Moorsel, Coline H. M.; Grutters, Jan C.Journal ContributionA1
572012New Idiopathic Pulmonary Fibrosis Guidelines: Some Unresolved Questionswuyts, W.A.; THOMEER, Michiel; Demeths, M.G.; Verleden, G.M.Journal ContributionA1
582012Treatment strategies for sarcoidosisViaene, E.; THOMEER, Michiel; Slabbynck, H; Wuyts, WJournal ContributionA1
192011Newer modes of treating interstitial lung diseaseWuyts, Wim A.; THOMEER, Michiel; Demedts, Maurits G.Journal ContributionA1
202011Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important differencedu Bois, Roland M.; Weycker, Derek; Albera, Carlo; Bradford, Williamson Z.; Costabel, Ulrich; Kartashov, Alex; King, Talmadge E.; Lancaster, Lisa; Noble, Paul W.; Sahn, Steven A.; THOMEER, Michiel; Valeyre, Dominique; Wells, Athol U.Journal ContributionA1
show all